Literature DB >> 29766320

Weaning from prolonged veno-venous extracorporeal membrane oxygenation (ECMO) after transfer to a specialized center: a retrospective study.

Frederik Seiler1, Franziska C Trudzinski1, Sabrina I Hörsch2, Annegret Kamp1, Carlos Metz1, Monika Flaig1, Mohammad Alqudrah1, Holger Wehrfritz1, Markus Kredel3, Ralf M Muellenbach4,3, Hendrik Haake5, Robert Bals1, Philipp M Lepper6.   

Abstract

Veno-venous extracorporeal membrane oxygenation (vvECMO) is increasingly used as rescue therapy in severe respiratory failure. In patients with pre-existent lung diseases or persistent lung injury weaning from vvECMO can be challenging. This study sought to investigate outcomes of patients transferred to a specialized ECMO center after prolonged ECMO therapy. We performed a retrospective analysis of all patients admitted to our medical intensive care unit (ICU) between 01/2013 and 12/2016 who were transferred from an external ICU after > 8 days on vvECMO. 12 patients on ECMO for > 8 days were identified. Prior to transfer, patients underwent ECMO therapy for 18 ± 9.5 days. Total time on ECMO was 60 ± 46.6 days. 11/12 patients could be successfully weaned from ECMO, 7/12 in the first 28 days after transfer (8 ± 8.8 ECMO-free days at day 28). In 7 patients, ECMO could be terminated after at least partial lung recovery, in 4 patients after salvage lung transplant. No patient died or needed re-initiation of ECMO therapy at day 28. In summary, weaning from vvECMO was feasible even after prolonged ECMO courses and salvage lung transplant could be avoided in most cases. Patients may benefit from transfer to a specialized ECMO center.

Entities:  

Keywords:  ARDS; ECMO; Lung failure; Lung transplant; Respiratory failure; Weaning

Mesh:

Year:  2018        PMID: 29766320     DOI: 10.1007/s10047-018-1046-1

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  16 in total

1.  Long-term ECMO treatment in Jehovah's Witness patient without transfusions.

Authors:  J Lindholm; K Palmér; B Frenckner
Journal:  Perfusion       Date:  2012-04-10       Impact factor: 1.972

2.  Prolonged duration ECMO for ARDS: futility, native lung recovery, or transplantation?

Authors:  Andrew A Rosenberg; Jonathan W Haft; Robert Bartlett; Theodore J Iwashyna; Steven K Huang; William R Lynch; Lena M Napolitano
Journal:  ASAIO J       Date:  2013 Nov-Dec       Impact factor: 2.872

3.  Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011.

Authors:  Christopher M Sauer; David D Yuh; Pramod Bonde
Journal:  ASAIO J       Date:  2015 Jan-Feb       Impact factor: 2.872

4.  Extracorporeal membrane oxygenation: evolving epidemiology and mortality.

Authors:  Christian Karagiannidis; Daniel Brodie; Stephan Strassmann; Erich Stoelben; Alois Philipp; Thomas Bein; Thomas Müller; Wolfram Windisch
Journal:  Intensive Care Med       Date:  2016-03-04       Impact factor: 17.440

5.  Prolonged Maintenance of VV ECMO for 104 Days with Native Lung Recovery in Acute Respiratory Failure.

Authors:  Seong Mi Moon; Hyun Lee; Ji Hoon Moon; Hee Kyung Kim; Jee Eun Park; Seonggyu Byeon; Gee Young Suh; Chi Ryang Chung
Journal:  ASAIO J       Date:  2016 Mar-Apr       Impact factor: 2.872

6.  Outcome of Adult Respiratory Failure Patients Receiving Prolonged (≥14 Days) ECMO.

Authors:  Joseph Posluszny; Peter T Rycus; Robert H Bartlett; Milo Engoren; Jonathan W Haft; William R Lynch; Pauline K Park; Krishnan Raghavendran; Lena M Napolitano
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

7.  Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.

Authors:  Ryan P Barbaro; Folafoluwa O Odetola; Kelley M Kidwell; Matthew L Paden; Robert H Bartlett; Matthew M Davis; Gail M Annich
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

8.  Experience and results with VV-ECMO for severe acute respiratory failure: weaning versus nonweaning.

Authors:  Yeon Joo Lee; Dong Jung Kim; Jun Sung Kim; Jae-Ho Lee; Choon-Taek Lee; Sanghoon Jheon; Young-Jae Cho
Journal:  ASAIO J       Date:  2015 Mar-Apr       Impact factor: 2.872

Review 9.  Venovenous extracorporeal membrane oxygenation for acute respiratory failure : A clinical review from an international group of experts.

Authors:  Eddy Fan; Luciano Gattinoni; Alain Combes; Matthieu Schmidt; Giles Peek; Dan Brodie; Thomas Muller; Andrea Morelli; V Marco Ranieri; Antonio Pesenti; Laurent Brochard; Carol Hodgson; Cecile Van Kiersbilck; Antoine Roch; Michael Quintel; Laurent Papazian
Journal:  Intensive Care Med       Date:  2016-03-23       Impact factor: 17.440

10.  Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study.

Authors:  Cecile Aubron; Allen C Cheng; David Pilcher; Tim Leong; Geoff Magrin; D Jamie Cooper; Carlos Scheinkestel; Vince Pellegrino
Journal:  Crit Care       Date:  2013-04-18       Impact factor: 9.097

View more
  1 in total

Review 1.  Journal of Artificial Organs 2018: the year in review : Journal of Artificial Organs Editorial Committee.

Authors:  Y Sawa; G Matsumiya; K Matsuda; E Tatsumi; T Abe; K Fukunaga; S Ichiba; T Taguchi; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; T Tsukiya; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2019-02-23       Impact factor: 1.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.